Advanced search
Publication Cover
Drug Delivery Volume 28, 2021 - Issue 1
Submit an article Journal homepage
2,148
Views
8
CrossRef citations to date
0
Altmetric
Research Article

An in vitro visual study of fugitive aerosols released during aerosol therapy to an invasively ventilated simulated patient

Marc Mac Giolla Eaina Research and Development, Science and Emerging Technologies, Aerogen, Galway, IrelandORCID Iconhttps://orcid.org/0000-0002-0211-2132
ORCID Icon,
Mary Joycea Research and Development, Science and Emerging Technologies, Aerogen, Galway, IrelandORCID Iconhttps://orcid.org/0000-0002-2035-0687
ORCID Icon &
Ronan MacLoughlina Research and Development, Science and Emerging Technologies, Aerogen, Galway, Ireland;b School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons, Dublin, Ireland;c School of Pharmacy and Pharmaceutical Sciences, Trinity College, Dublin, IrelandCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-3164-1607
ORCID Icon
Pages 1496-1500 | Received 28 Apr 2021, Accepted 28 Jun 2021, Published online: 14 Jul 2021

References

  • Alhazzani W, Møller MH, Arabi YM, et al. (2020). Surviving sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19). Intensive Care Med 46:854–87.
  • Ari A, Fink JB, Pilbeam SP. (2016). Secondhand aerosol exposure during mechanical ventilation with and without expiratory filters: an in-vitro study. Indian J Respir Care 5:677–82.
  • Ari A. (2020). Practical strategies for a safe and effective delivery of aerosolized medications to patients with COVID-19. Respir Med 167:105987.
  • Bishop MJ, Larson RP, Buschman DL. (1990). Metered dose inhaler aerosol characteristics are affected by the endotracheal tube actuator/adapter used. Anesthesiology 73:1263–5.
  • British Thoracic Society. (2021). COVID-19: information for the respiratory community. Advice about the safety of nebuliser use. British Thoracic Society. Last Updated: 03 June 2021.
  • Cazzola M, Ora J, Bianco A, et al. (2021). Guidance on nebulization during the current COVID-19 pandemic. Respir Med 176:106236.
  • Clark R, Edholm O. (1985). Man and his thermal environment. London: Arnold.
  • Clark RP, De Calcina-Goff ML. (2009). Some aspects of the airborne transmission of infection. J R Soc Interface 6:S767–S82.
  • Dhand R, Li J. (2020). Coughs and sneezes: their role in transmission of respiratory viral infections, including SARS-CoV-2. Am J Respir Crit Care Med 202:651–9.
  • Diot P, Morra L, Smaldone GC. (1995). Albuterol delivery in a model of mechanical ventilation. Comparison of metered-dose inhaler and nebulizer efficiency. Am J Respir Crit Care Med 152:1391–4.
  • Ehrmann S, Roche-Campo F, Sferrazza Papa GF, et al. (2013). Aerosol therapy during mechanical ventilation: an international survey. Intensive Care Med 39:1048–56.
  • Ferrando C, Sipmann FS, Artigas RM, et al. (2020). Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS. Intensive Care Med 46:2200–11.
  • Fink JB, Ehrmann S, Li J, et al. (2020). Reducing aerosol-related risk of transmission in the era of COVID-19: an interim guidance endorsed by the International Society of Aerosols in Medicine. J Aerosol Med Pulm Drug Deliv 33:1–5.
  • Global Initiative for Asthma. (2020). Global initiative for asthma: global strategy for asthma management and prevention (updated 2020). Rev Fr D’Allergol D’Immunol Clin 36:685–704.
  • Grasselli G, Zangrillo A, Zanella A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA 2020;323:1574–81.
  • Joyce M, McGrath JA, Mac Giolla Eain M, et al. (2021). Nebuliser type influences both patient-derived bioaerosol emissions and ventilation parameters during mechanical ventilation. Pharmaceutics 13:199.
  • Lewis HE, Foster AR, Mullan BJ, et al. (1969). Aerodynamics of the human microenvironment. Lancet 293:1273–7.
  • Li J, Fink JB, Ehrmann S. (2020). High-flow nasal cannula for COVID-19 patients: low risk of bio-aerosol dispersion. Eur Respir J 55:2000892.
  • McGrath JA, O’Toole C, Bennett G, et al. (2019). Investigation of fugitive aerosols released into the environment during high-flow therapy. Pharmaceutics 11:254–13.
  • O’Toole C, McGrath JA, Joyce M, et al. (2020). Fugitive aerosol therapy emissions during mechanical ventilation: in vitro assessment of the effect of tidal volume and use of protective filters. Aerosol Air Qual Res 20:2604–13.
  • Rau JL, Harwood RJ, Groff JL. (1992). Evaluation of a reservoir device for metered-dose bronchodilator delivery to intubated adults. An in vitro study. Chest 102:924–30.
  • Razzak JA, Bhatti JA, Tahir MR, Pasha-Razzak O. (2020). Initial estimates of COVID-19 infections in hospital workers in the United States during the first wave of pandemic. PLOS One 15:e0242589.
  • Respiratory Care Committee of Chinese Thoracic Society. (2020). Expert consensus on preventing nosocomial transmission during respiratory care for critically ill patients infected by 2019 novel coronavirus pneumonia. Chin J Tuberc Respir Dis 43:288–96.
  • Yang X, Yu Y, Xu J, et al. (2020). Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 8:475–81.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.